Suchergebnisse - "Yamamoto, Shohei"

PubPharm (17)

1

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults : An open-label, single-center, non-randomized, controlled study in Japan

enthalten in: Human vaccines & immunotherapeutics | 2023

von Terada-Hirashima, J. | Takamatsu, Y. | Shimizu, Y. | +13

2

Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID : A Propensity Score-Matched Analysis

enthalten in: The Journal of infectious diseases | 2023

von Yamamoto, S. | Matsuda, K. | Maeda, K. | +17

3

Kinetics and durability of nucleocapsid-specific antibodies after SARS-CoV-2 reinfection

enthalten in: The Journal of infection | 2023

von Yamamoto, S. | Mizoue, T. | Konishi, M. | +6

4

The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the BNT162b2 mRNA vaccine : An observational study

enthalten in: Vaccine | 2023

von Inoue, Y. | Li, Y. | Yamamoto, S. | +8

5

Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Yamamoto, S. | Oshiro, Y. | Inamura, N. | +10

6

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2

enthalten in: BMC infectious diseases | 2023

von Yamamoto, S. | Matsuda, K. | Maeda, K. | +11

7

Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine

enthalten in: Infection | 2023

von Yamamoto, S. | Tanaka, A. | Oshiro, Y. | +4

8

Dyslipidemia and SARS-CoV-2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among healthcare workers in Japan

enthalten in: Diabetes/metabolism research and reviews | 2023

von Islam, Z. | Yamamoto, S. | Mizoue, T. | +6

9

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Yamamoto, S. | Matsuda, K. | Maeda, K. | +13

10

Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination : A cross-sectional study

enthalten in: PloS one | 2023

von Li, J. | Nakagawa, T. | Kojima, M. | +13